Clinical trial

Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin

NCT00569998

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-08-01

PhasePHASE3

Study timeline

Study start (unknown)2003-08-01Date precision: month

Registry last updated2017-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 1unresolved

Diabetes Mellitus, Type 2unresolved

Delivery Systemsunresolved

Interventions

NovoPen™ 4DEVICE

NovoPen® 3DEVICE

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

ViennaAustria2 RomaItaly1 AmsterdamNetherlands1 MünchenGermany1 CologneGermany1 RotterdamNetherlands1 LeedsUnited Kingdom1 TorinoItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00569998 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.